Exscientia

Exscientia plc is a biotechnology firm. The company is creating the first clinically verified AI-driven platform to improve treatment results for cancer patients, as well as medication candidates designed by AI for use in clinical trials. Exscientia provides services to clients in the UK. Exscientia is a biotech firm that employs an AI platform that covers the entire drug development process, from ideation to clinical trials. Exscientia's mission is to accelerate drug discovery through the use of innovative technologies.

They can help people lead longer, healthier, and more fruitful lives if we use AI to speed up and improve the process of precision engineering medications. They're an AI-powered drug discovery firm that uses both AI design and high-precision data gathering to advance the field. When combined, they boost the efficiency and accuracy of AI and ML pipelines. Pre-clinical drug development can be greatly sped up by our combined design and experimentation efforts, which will ultimately benefit patients all around the world.

Founded: 2012
Headquarters: UK
Website: https://www.exscientia.ai/